Access to Innovation for Medicare Patients Act of 2003
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2003
Read twice and referred to the Committee on Finance.
Feb 27, 2003
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Access to Innovation for Medicare Patients Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed as a complete replacement for a drug or a biological that otherwise cannot be self-administered.
What's happening now
Read twice and referred to the Committee on Finance.
Bill text
1 version
- Introduced in Senate Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
3
Cite this page
U.S. Congress. (2026). S. 465: Access to Innovation for Medicare Patients Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-S-465/
"S. 465: Access to Innovation for Medicare Patients Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-465/.
S. 465, 108th Cong. (2026), https://openamerica.io/bill/108-S-465/.
[S. 465: Access to Innovation for Medicare Patients Act of 2003](https://openamerica.io/bill/108-S-465/)